Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

HIV Drugs May Raise Heart Attack Risk


Related Encyclopedia
 border=
Abdominoplasty
Abscess
Acidophilus
Actinomycosis
More...

Related Healthscout Videos
 border=
Howard: The Helping Hand for Stroke Survivors
Fixing Torn Hearts
Medicine's Next Big Thing? Growing Hearts
Fighting HIV
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Abilify
Accupril
Actonel
Altace
More...

Related News Articles
 border=
Extra Pounds During and Between Pregnancies Can Pose Problems
Dealing Cervical Cancer a Knockout Blow
Health Tip: Talking to a Person With Alzheimer's Disease
Talk Therapy Proves Effective for Terminal Cancer Patients
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

But what about the role of the powerful drugs included in HAART? Typically, these drugs fall into a variety of classes, including enzyme-targeted agents called protease inhibitors.

In the new, prospective study, a group of European and American researchers analyzed data on more than 23,000 HIV-infected patients treated for an average of 4.5 years at 188 clinics in 21 countries.

Nearly all -- 93.6 percent -- of the patients received some form of antiretroviral therapy.

Text Continues Below



According to the researchers, 345 of the patients experienced either a fatal or non-fatal heart attack during the course of the study.

Breaking it down by treatment type, Lundgren's group found that the use of protease inhibitors boosted a patient's risk for heart attack by 16 percent for every year they were on the drugs.

"This association was partly explained by how these drugs adversely affect cholesterol levels," Lundgren noted.

Without more research, the small but significant hike in risk remains tough to explain, Lundgren said. However, he noted that "there is emerging evidence to suggest that protease inhibitors adversely affect the activity of cells (called macrophages) involved in the atherosclerotic process in the arterial wall."

Another major class of HIV-suppressing drugs, called non-nucleoside reverse-transcriptase inhibitors, had no effect on heart attack risk, the study found.

None of this means that HIV-positive individuals should forego HAART, which has kept thousands of infected people alive and relatively healthy since the drugs were introduced more than a decade ago.

"All they are saying here is that the increase in (heart attack) risk is there, and that doctors had better look out for it," said Rowena Johnston, vice president of research at the Foundation for AIDS Research (amfAR), based in New York City. "Doctors have to be vigilant; it adds a new level of complication to the person's care," she said.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/25/2007

Related Links
 border=
From Healthscout's partner site on genital herpes, HerpesConnection.com
Learn about genital herpes symptoms
What are herpes treatment options?
Get the details about herpes simplex 1 and 2.





New Features

New ADHD Site!

SOURCES: Jens D. Lundgren, M.D., professor, University of Copenhagen, and chief physician and head, Copenhagen HIV Program, Hvidovre University Hospital, Denmark; Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research, New York City; April 26, 2007, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map